Position in ALNY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$185,877,294
-$61,462,587 QoQ
Shares Held
617,471
-17.4% QoQ
Ownership
0.461%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#38
of 784 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Amundi holds $2,427,056,148 across 70 Biotechnology names. ALNY ranks #4 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,546,509 | $768,197,412 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,013,540 | $631,982,729 | |
| 3 | RPRX |
Royalty Pharma plc
|
3,723,864 | $208,797,052 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
617,471 | $185,877,294 | |
| 5 | INCY |
Incyte Corp
|
1,181,498 | $133,934,612 | |
| 6 | TECH |
BIO-TECHNE Corp
|
1,827,241 | $129,094,576 | |
| 7 | MRNA |
Moderna, Inc.
|
888,779 | $62,241,193 | |
| 8 | ARGX |
Argenx SE
|
65,122 | $60,418,237 |
All Filings in ALNY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,877,294 | 617,471 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $247,339,881 | 747,544 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $242,120,733 | 608,879 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $175,228,032 | 384,272 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $128,537,829 | 394,179 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $122,857,743 | 454,995 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $116,784,581 | 496,301 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $163,180,791 | 593,320 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $179,161,470 | 737,290 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $111,499,257 | 746,064 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $136,224,956 | 711,692 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $108,802,968 | 614,359 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $128,165,426 | 674,768 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $130,965,203 | 653,780 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $158,639,211 | 667,533 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $239,373,137 | 1,195,909 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $132,217,973 | 906,534 | Shares | Defined | 2022-09-02 | |
| 2022-03-31 | $142,870,577 | 874,950 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $43,116,558 | 254,255 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $49,160,269 | 260,369 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,329,657 | 214,309 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||